U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06893965) titled 'Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL' on March 12.
Brief Summary: In just a few years, intravitreal injections have become a standard method of administration for certain retinal deseases (age-related macular degeneration [AMD], diabetic edematous maculopathy or retinal vein occlusion [RVO]). Thus, vascular endothelial growth factor (anti-VEGF) inhibitors are injected repetitively, every 4 to 6 weeks, in some patients in order to treat such pathologies.
It is established that each of these IVTs has repercussions on the intraocular pressure (IOP) of patients. They immediately present with an intraocul...